- Review
Microalgal fucoxanthin is a marine xanthophyll relevant to environmental medicine because it links sustainable resource recovery with prevention-oriented research on environmentally driven metabolic disorders. Methods: This critical narrative review synthesizes recent peer-reviewed studies, related reviews, and regulatory documents on fucoxanthin chemistry, microalgal sources, cultivation, downstream processing, bioavailability enhancement, safety, and translational evidence. Findings: Diatoms and haptophytes, including Phaeodactylum tricornutum, Tisochrysis lutea, Isochrysis galbana, Nitzschia laevis, Cyclotella meneghiniana, and Conticribra weissflogii, are candidate production platforms, while Poterioochromonas malhamensis currently lacks the safety and regulatory evidence required for food use. Evidence for metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, diabetes, inflammation, lipid metabolism, microbiota modulation, and chemoprevention remains predominantly preclinical or is derived from macroalgal or combined marine formulations. No randomized clinical trial evaluating a standardized microalgal fucoxanthin formulation with pharmacokinetic characterization was identified in the literature reviewed. Wastewater-derived biomass faces a strict regulatory barrier to oral human use and is currently best suited to environmental and agricultural applications unless contaminant clearance and product-specific safety are demonstrated. Conclusions: Bioavailability is constrained by instability, poor aqueous dispersibility, intestinal de-esterification to fucoxanthinol, and hepatic oxidation to amarouciaxanthin A, but encapsulation and lipid-matrix systems are promising. Translation requires authenticated strains, human-grade cultivation, validated processing, product-specific toxicology, regulatory dossiers, and controlled clinical studies.
9 November 2026




















![Bodies and minds self-assemble from single cells as a process of alignment and autopoiesis. (A) Most complex biological forms begin as one cell—a fertilized oocyte, commonly thought to be well-described by the laws of physics and chemistry. (B) A gradual, slow process of developmental morphogenesis results in the final form of the organism, which may have complex structure and a mind which may not believe it is a “machine”. Our transformation from a chemical soup into an active embodied mind is continuous but heterogeneous: (C) while we commonly think of ourselves as a unified intelligence with a “centralized” brain, the fact is that even the pineal gland, of which there is only one in the brain, is made of cells (C′) and those cells in turn are made of myriad other active components (C″)—we are a collective intelligence at all scales. (D) The creation of an “individual” out of an excitable medium such as an embryonic blastoderm with hundreds of thousands of cells is a dynamic process that is not hardwired: scratches made in that blastoderm would result in independent self-organization in each island, resulting in multiple embryos forming. This reveals the potentiality for some non-pre-determined number of minds to arise out of the same substrate. Images in (A,B,D) courtesy of Jeremy Guay of Peregrine Creative, used previously in [29]. Image (B) used with permission from [30]. Image in (C′) courtesy of Jose Calvo, Science Photo Library. Image in (C″) courtesy of Evan Ingersoll and Gaël McGill. Image (D) used with permission from [31].](https://mdpi-res.com/philosophies/philosophies-11-00161/article_deploy/html/images/philosophies-11-00161-g001-550.jpg)






